Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany
Szejko N, Becher E, Heimann F, Grotenhermen F, Müller-Vahl KR (2024)
Pharmacopsychiatry .
Zeitschriftenaufsatz
| E-Veröff. vor dem Druck | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Szejko, Natalia;
Becher, EvaUniBi ;
Heimann, Florian;
Grotenhermen, Franjo;
Müller-Vahl, Kirsten R.
Abstract / Bemerkung
Background Up to now, it is unclear whether different medicinal cannabis (MC) strains are differently efficacious across different medical conditions. In this study, the effectiveness of different MC strains was compared depending on the disease to be treated. Methods This was an online survey conducted in Germany between June 2020 and August 2020. Patients were allowed to participate only if they received a cannabis -based treatment from pharmacies in the form of cannabis flowers prescribed by a physician. Results The survey was completed by n=1,028 participants. Most participants (58%) have used MC for more than 1 year, on average, 5.9 different strains. Bedrocan (pure tetrahydrocannabinol to pure cannabidiol [THC:CBD]=22:<1) was the most frequently prescribed strain, followed by Bakerstreet (THC:CBD=19:<1) and Pedanios 22/1 (THC:CBD=22:1). The most frequent conditions MC was prescribed for were different pain disorders, psychiatric and neurological diseases, and gastrointestinal symptoms. Overall, the mean patient-reported effectiveness was 80.1% (range, 0-100%). A regression model revealed no association between the patient-reported effectiveness and the variety. Furthermore, no influence of the disease on the choice of the MC strain was detected. On average, 2.1 side effects were reported (most commonly dry mouth (19.5%), increased appetite (17.1%), and tiredness (13.0%)). However, 29% of participants did not report any side effects. Only 398 participants (38.7%) indicated that costs for MC were covered by their health insurance. Conclusions Patients self-reported very good efficacy and tolerability of MC. There was no evidence suggesting that specific MC strains are superior depending on the disease to be treated.
Stichworte
medicinal cannabis;
tetrahydrocannabinol;
cannabidiol;
patients';
experience;
side effects
Erscheinungsjahr
2024
Zeitschriftentitel
Pharmacopsychiatry
ISSN
0176-3679
eISSN
1439-0795
Page URI
https://pub.uni-bielefeld.de/record/2988494
Zitieren
Szejko N, Becher E, Heimann F, Grotenhermen F, Müller-Vahl KR. Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany. Pharmacopsychiatry . 2024.
Szejko, N., Becher, E., Heimann, F., Grotenhermen, F., & Müller-Vahl, K. R. (2024). Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany. Pharmacopsychiatry . https://doi.org/10.1055/a-2261-2269
Szejko, Natalia, Becher, Eva, Heimann, Florian, Grotenhermen, Franjo, and Müller-Vahl, Kirsten R. 2024. “Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany”. Pharmacopsychiatry .
Szejko, N., Becher, E., Heimann, F., Grotenhermen, F., and Müller-Vahl, K. R. (2024). Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany. Pharmacopsychiatry .
Szejko, N., et al., 2024. Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany. Pharmacopsychiatry .
N. Szejko, et al., “Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany”, Pharmacopsychiatry , 2024.
Szejko, N., Becher, E., Heimann, F., Grotenhermen, F., Müller-Vahl, K.R.: Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany. Pharmacopsychiatry . (2024).
Szejko, Natalia, Becher, Eva, Heimann, Florian, Grotenhermen, Franjo, and Müller-Vahl, Kirsten R. “Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany”. Pharmacopsychiatry (2024).
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 38471525
PubMed | Europe PMC
Suchen in